[Effects of geniposide on treating experimental chronic prostatitis rats]

Area of Science:

• Pharmacology
• Natural Product Chemistry
• Urology

Background:

• Chronic prostatitis (CP) is a common condition with limited effective treatments.
• Geniposide, a bioactive compound from Gardenia jasminoides, has demonstrated anti-inflammatory properties.
• Investigating geniposide's therapeutic potential for CP is crucial for developing novel treatments.

Purpose of the Study:

• To evaluate the efficacy of geniposide in an experimental rat model of chronic prostatitis.
• To assess the impact of geniposide on key biochemical and histological markers of CP.

Main Methods:

• An experimental rat model of chronic prostatitis was established.
• Rats were treated with Qianliekang tablets or varying doses of geniposide (high, middle, low).
• Prostate index, white blood cell (WBC) count, lecithin corpuscle levels, LDH5/LDH1 ratio, and prostatic histopathology were analyzed.

Main Results:

• Geniposide treatment (high and middle doses) and Qianliekang tablets significantly reduced prostate index, WBC count, and LDH5/LDH1 ratio.
• Lecithin corpuscle quantities were significantly increased in geniposide-treated and Qianliekang tablet groups.
• Histological analysis showed decreased inflammatory cells and fibroblasts, and increased glandular organ quantity and glandular cavity area with geniposide treatment.

Conclusions:

• High and middle doses of geniposide effectively reduce leukocyte infiltration and fibrous tissue hyperplasia in CP rats.
• Geniposide treatment helps restore the secretory function of the prostate.
• Geniposide exhibits significant therapeutic potential for treating chronic prostatitis.